Clover Health to Report Third Quarter 2026 Financial Results on November 4, 2026

Clover Health (Nasdaq: CLOV) will release its third-quarter 2026 financial results after the market closes on November 4, 2026.

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

Clover Health (Nasdaq: CLOV) will release its third-quarter 2026 financial results after the market closes on November 4, 2026.

Management will host a webcast at 5:00 p.m. Eastern Time that day to discuss quarterly business and financial performance. The live and archived webcast will be available through the company’s Investor Relations website, with the archive accessible for 12 months.

Key Figures

Financial results release: November 4, 2026

Financial results release: November 4, 2026; Third quarter 2026; after market close

Key Terms

ppo, hmo

2 terms

ppo technical

"we provide PPO and HMO Medicare Advantage plans"

A PPO, or preferred provider organization, is a type of health insurance plan that gives members a network of doctors and hospitals who agree to lower fees, while still allowing patients to see providers outside the network at higher cost. Investors care because PPOs influence how medical services are paid for and used, affecting revenue and margins for insurers, hospitals, drug makers and companies that serve employer health plans—think of it as a merchant discount program that shapes who customers choose and what they pay.

hmo technical

"we provide PPO and HMO Medicare Advantage plans"

HMO stands for Health Maintenance Organization, a type of managed health insurance plan that gives members access to a network of doctors and hospitals for a fixed premium and generally requires using in-network providers or referrals for specialists. Investors watch HMO performance because membership levels, cost controls and care network agreements directly affect revenue, profit margins and regulatory exposure—think of it as a subscription service that must balance member satisfaction with cost containment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

10/07/2026 - 04:05 PM

WILMINGTON, Del., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial results after the market closes on Wednesday, November 4, 2026. The Company’s management will host a webcast presentation at 5:00 p.m. Eastern Time on the same day to discuss the company’s business and financial performance for the quarter.

Third Quarter 2026 Conference Webcast Details:

What: Clover Health’s Third Quarter 2026 Earnings Conference Call
When: Wednesday, November 4, 2026, at 5:00 p.m. Eastern Time
Webcast: To access the webcast, you may register at https://clover-health-3q-2026-earnings.open-exchange.net/.

A live and archived webcast of the conference call will also be accessible from the Investor Relations section of Clover Health’s website at https://investors.cloverhealth.com/ for 12 months.

About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence, Congestive Heart Failure, Chronic Obstructive Pulmonary Disease, and in Underserved Populations as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.

Investor Relations:
Ryan Schmidt
investors@cloverhealth.com

Press Inquiries:
press@cloverhealth.com